GemPharmatech Co., Ltd. (SHA:688046)
China flag China · Delayed Price · Currency is CNY
18.81
-0.58 (-2.99%)
At close: Jun 1, 2026

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Commercial Mouse Model Sales
438.77M-
152.60M--
Functional Efficacy Business
200.19M-
32.01M--
Custom Breeding Business
83.99M-
50.06M--
Model Creation Business
47.48M-
24.17M--
Agent Import and Export and Others
22.24M-
1.62M--
Unallocated Other Operations
723.07K-
1.47M--
Biotechnology
--
-192.72M53.29M
Biotechnology Growth
--
-261.64%-
Total
793.39M-
261.92M192.72M53.29M
Total Growth
--
35.91%261.64%-

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
China
640.78M-
---
Overseas
151.88M-
-2.98M726.40K
Overseas Growth
--
-310.63%-
East China
--
-108.85M27.63M
East China Growth
--
-293.97%-
Central China Region
--
-10.05M1.96M
Central China Region Growth
--
-413.55%-
North China
--
-26.03M10.19M
North China Growth
--
-155.45%-
Southern China
--
-28.42M9.65M
Southern China Growth
--
-194.50%-
Northwestern Region
--
-1.40M403.50K
Northwestern Region Growth
--
-246.07%-
Southwest Region
--
-10.82M2.21M
Southwest Region Growth
--
-389.63%-
Northeast China Region
--
-2.42M522.40K
Northeast China Region Growth
--
-362.98%-
Total
792.67M-
-190.98M53.29M
Total Growth
--
-258.37%-
Source: S&P Global Market Intelligence.